Enzon Pharmaceuticals Inc. (ENZN) Stock News, Earnings & History
(NASDAQ:ENZN) Healthcare
Enjoy Interactive Tools and Indicators
52wk high:
7.47
52wk low:
1.54
EPS:
0.02
P/E:
113.33
Div Rate:
N/A
Yield:
N/A
Market Cap:
74.34M
Avg Vol (3m):
367,330
Latest Headlines
No articles on Enzon Pharmaceuticals Inc. in the past week.
Insider Trading Cheat Sheet
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
| LEBUHN ROBERT | Director | Aug 14 | Sale | 6.58 | 5,820 | 38,308 | 98,115 | Aug 15 11:53 AM |
| LEBUHN ROBERT | Director | Aug 10 | Sale | 6.58 | 1,933 | 12,720 | 103,935 | Aug 13 11:56 AM |
| HEBARD GEORGE | Interim PEO and Interim COO | Jun 20 | Buy | 6.88 | 5,000 | 34,395 | 18,737 | Jun 21 05:17 PM |
| Rackear Andrew D. | VP and General Counsel | Jun 05 | Sale | 6.81 | 1,614 | 10,983 | 56,720 | Jun 06 07:44 PM |
| Conover Charles | SVP, R&D Program Management | Jun 05 | Sale | 6.78 | 25,000 | 169,500 | 57,213 | Jun 06 07:42 PM |
Wall St. Cheat Sheet has been featured in these fine media outlets:
